The particular competence of the Institute for Biosafety in Plant Biotechnology (SB) is linking individual research with legally based obligations which mainly result from the Gene Technology Act.
The Institute SB is involved in the approval procedure for the release and marketing of genetically modified organisms (GMO). Within the scope of biosafety research and research accompanying the cultivation of plants, safety aspects and possible effects of novel biotechnological techniques on the ecological balance and sustainable agriculture are investigated. The criteria and measures required to monitor the cultivation of genetically modified plants (GMP) are developed. The Institute is active in national and international committees for the safety evaluation of GMO and, as a consequence, is in close cooperation with researchers on a national and international level.